The most prominent of the newer risk factors has been C-reactive protein (CRP), based on numerous publications demonstrating its association with CVD. The recent Scientific Statement of the ...
C-reactive protein (CRP) is a nonspecific, acute-phase protein that rises in response to infectious and noninfectious inflammatory processes. Good evidence exists to support the use of CRP ...
Long-term treatment with guselkumab is associated with sustained improvements in joint/skin symptoms and disease activity among patients with active PsA.